These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6544523)

  • 1. [Anticomplement function of heparin].
    Huang SW
    Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):360-3. PubMed ID: 6544523
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.
    Ivanovska N; Yossifova T; Vassileva E; Kostova I
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):557-62. PubMed ID: 7760580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mouse complement activity by contaminants of technical grade pentachlorophenol.
    White KL; Anderson AC
    Agents Actions; 1985 Jul; 16(5):385-92. PubMed ID: 4050617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticomplement activity of lysine complexes of propolis phenolic constituents and their synthetic analogs.
    Georgieva P; Ivanovska N; Bankova V; Popov S
    Z Naturforsch C J Biosci; 1997; 52(1-2):60-4. PubMed ID: 9090067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological modulation of complement system: proposition of anticomplement therapy].
    Yamauchi Y
    Nihon Rinsho; 1981 Apr; 39(4):1791-800. PubMed ID: 7031292
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological manipulation of complement system.
    Asghar SS
    Pharmacol Rev; 1984 Dec; 36(4):223-44. PubMed ID: 6395140
    [No Abstract]   [Full Text] [Related]  

  • 8. Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system.
    Türk H; Haag R; Alban S
    Bioconjug Chem; 2004; 15(1):162-7. PubMed ID: 14733596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clionasterol: a potent inhibitor of complement component C1.
    Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
    Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, partial characterisation and complement inhibiting activity of a new glycoprotein from Cuscuta europea.
    Zhelev ZD; Stanilova SA; Carpenter BG
    Biochem Biophys Res Commun; 1994 Jul; 202(1):186-94. PubMed ID: 8037713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of complement by gold sodium thiomalate.
    Hasselbacher P
    J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of in vitro inhibition of activation of the classical and alternative pathways of human complement by the magnesium and sodium salts of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA).
    Feuillard J; Maillet F; Goldschmidt P; Weiss L; Kazatchkine MD
    Agents Actions; 1991 Mar; 32(3-4):343-6. PubMed ID: 1862751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
    Caughman GB; Boackle RJ; Vesely J
    Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of equine complement activity by polysulfated glycosaminoglycans.
    Rashmir-Raven AM; Coyne CP; Fenwick BW; Gaughan EM; Andrews GA; DeBowes RM
    Am J Vet Res; 1992 Jan; 53(1):87-90. PubMed ID: 1539920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D.
    González-Rubio C; González-Muñiz R; Jiménez-Clavero MA; Fontán G; López-Trascasa M
    Biochim Biophys Acta; 1996 Jul; 1295(2):174-8. PubMed ID: 8695643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro anti-complementary activity of flavonoids from olive (Olea europaea L.) leaves.
    Pieroni A; Heimler D; Pieters L; van Poel B; Vlietinck AJ
    Pharmazie; 1996 Oct; 51(10):765-8. PubMed ID: 8941947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes.
    Leslie RG; Nielsen CH
    Immunology; 2004 Jan; 111(1):86-90. PubMed ID: 14678202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of C1s and C1 inactivator in the presence of heparin, dextran sulfate and protamine sulfate.
    Takada A; Takada Y
    Thromb Res; 1980 Jun; 18(6):847-59. PubMed ID: 6158117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.